Jacobi Capital Management LLC Adamis Pharmaceuticals Corp Transaction History

Jacobi Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$0.4 - $1.01 $10,000 - $25,250	-25,000 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$0.7 - $1.46 $1,694 - $3,534	-2,421 Reduced 8.83%	25,000 $18,000
Q2 2019 Aug 07, 2019	BUY	$1.26 - $2.23 $31,500 - $55,750	25,000 Added 1032.63%	27,421 $36,000
Q4 2018 Feb 11, 2019	SELL	$2.1 - $3.21 $10,500 - $16,050	-5,000 Reduced 67.38%	2,421 $5,000
Q3 2017 Nov 02, 2017	SELL	$4.5 - $5.65 $11,605 - $14,571	-2,579 Reduced 25.79%	7,421 $39,000
Q2 2017 Aug 10, 2017	BUY	N/A	10,000	10,000 $56,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.